{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-05-19",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "submissions": [
        {
          "submission_type": "ORIG",
          "submission_number": "1",
          "submission_status": "AP",
          "submission_status_date": "20210526",
          "review_priority": "STANDARD",
          "submission_class_code": "TYPE 4",
          "submission_class_code_description": "Type 4 - New Combination",
          "application_docs": [
            {
              "id": "67603",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/214846s000lbl.pdf",
              "date": "20210526",
              "type": "Label"
            },
            {
              "id": "67611",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2021/214846Orig1s000ltr.pdf",
              "date": "20210527",
              "type": "Letter"
            },
            {
              "id": "67897",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/nda/2021/214846Orig1s000TOC.html",
              "date": "20210624",
              "type": "Review"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "7",
          "submission_status": "AP",
          "submission_status_date": "20240430",
          "review_priority": "STANDARD",
          "submission_class_code": "EFFICACY",
          "submission_class_code_description": "Efficacy",
          "application_docs": [
            {
              "id": "78328",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2024/214846s007lbl.pdf",
              "date": "20240501",
              "type": "Label"
            },
            {
              "id": "78340",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2024/214846Orig1s007ltr.pdf",
              "date": "20240502",
              "type": "Letter"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "5",
          "submission_status": "AP",
          "submission_status_date": "20230127",
          "review_priority": "STANDARD",
          "submission_class_code": "EFFICACY",
          "submission_class_code_description": "Efficacy",
          "application_docs": [
            {
              "id": "73316",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2023/214846s005lbl.pdf",
              "date": "20230130",
              "type": "Label"
            },
            {
              "id": "73331",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2023/214846Orig1s005ltr.pdf",
              "date": "20230130",
              "type": "Letter"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "8",
          "submission_status": "AP",
          "submission_status_date": "20240717",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling",
          "application_docs": [
            {
              "id": "79114",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2024/214846Orig1s008ltr.pdf",
              "date": "20240718",
              "type": "Letter"
            },
            {
              "id": "79140",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2024/214846s008lbl.pdf",
              "date": "20240722",
              "type": "Label"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "6",
          "submission_status": "AP",
          "submission_status_date": "20230127",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling",
          "application_docs": [
            {
              "id": "73317",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2023/214846s006lbl.pdf",
              "date": "20230130",
              "type": "Label"
            },
            {
              "id": "73330",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2023/214846Orig1s006ltr.pdf",
              "date": "20230130",
              "type": "Letter"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "2",
          "submission_status": "AP",
          "submission_status_date": "20220805",
          "review_priority": "STANDARD",
          "submission_class_code": "EFFICACY",
          "submission_class_code_description": "Efficacy",
          "application_docs": [
            {
              "id": "71740",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2022/214846Orig1s002ltr.pdf",
              "date": "20220808",
              "type": "Letter"
            },
            {
              "id": "71748",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/214846s002lbl.pdf",
              "date": "20220808",
              "type": "Label"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "12",
          "submission_status": "AP",
          "submission_status_date": "20250827",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling",
          "application_docs": [
            {
              "id": "83215",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2025/214846s012lbl.pdf",
              "date": "20250828",
              "type": "Label"
            },
            {
              "id": "83227",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2025/214846Orig1s012ltr.pdf",
              "date": "20250829",
              "type": "Letter"
            }
          ]
        }
      ],
      "application_number": "NDA214846",
      "sponsor_name": "SUMITOMO PHARMA AM",
      "openfda": {
        "application_number": [
          "NDA214846"
        ],
        "brand_name": [
          "MYFEMBREE"
        ],
        "generic_name": [
          "RELUGOLIX, ESTRADIOL HEMIHYDRATE, AND NORETHINDRONE ACETATE"
        ],
        "manufacturer_name": [
          "Sumitomo Pharma America, Inc"
        ],
        "product_ndc": [
          "72974-415"
        ],
        "product_type": [
          "HUMAN PRESCRIPTION DRUG"
        ],
        "route": [
          "ORAL"
        ],
        "substance_name": [
          "ESTRADIOL HEMIHYDRATE",
          "NORETHINDRONE ACETATE",
          "RELUGOLIX"
        ],
        "rxcui": [
          "2556799",
          "2556800"
        ],
        "spl_id": [
          "d0b51ef8-0118-4b78-a83f-73338d6dab9b"
        ],
        "spl_set_id": [
          "fc3feb73-cc84-43a8-aa32-b262460495e8"
        ],
        "package_ndc": [
          "72974-415-01",
          "72974-415-99"
        ],
        "nui": [
          "N0000175839",
          "N0000175084",
          "N0000008638",
          "N0000190118",
          "N0000187064",
          "N0000190113",
          "N0000185503"
        ],
        "pharm_class_epc": [
          "Gonadotropin Releasing Hormone Receptor Antagonist [EPC]"
        ],
        "pharm_class_moa": [
          "Gonadotropin Releasing Hormone Receptor Antagonists [MoA]",
          "Cytochrome P450 3A Inducers [MoA]",
          "Cytochrome P450 2B6 Inducers [MoA]",
          "Breast Cancer Resistance Protein Inhibitors [MoA]",
          "P-Glycoprotein Inhibitors [MoA]"
        ],
        "pharm_class_pe": [
          "Decreased GnRH Secretion [PE]"
        ],
        "unii": [
          "CXY7B3Q98Z",
          "9S44LIC7OJ",
          "P76B05O5V6"
        ]
      },
      "products": [
        {
          "product_number": "001",
          "reference_drug": "Yes",
          "brand_name": "MYFEMBREE",
          "active_ingredients": [
            {
              "name": "ESTRADIOL",
              "strength": "1MG"
            },
            {
              "name": "NORETHINDRONE ACETATE",
              "strength": "0.5MG"
            },
            {
              "name": "RELUGOLIX",
              "strength": "40MG"
            }
          ],
          "reference_standard": "Yes",
          "dosage_form": "TABLET",
          "route": "ORAL",
          "marketing_status": "Prescription"
        }
      ]
    }
  ]
}